(Q34580419)

3 August 2017

1 reference

title

Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies (English)

1 reference

3 August 2017

1 reference

1 reference

Dimitrios Vassilopoulos

series ordinal

1

object named as

Dimitrios Vassilopoulos

1 reference

3 August 2017

2

Leonard H Calabrese

1 reference

3 August 2017

language of work or name

1 reference

1 March 2002

1 reference

3 August 2017

published in

Arthritis & Rheumatology

1 reference

3 August 2017

volume

46

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

585-597

1 reference

Hepatitis C virus infection

3 August 2017

cites work

1 reference

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis

21 January 2018

1 reference

Replication of hepatitis C virus

21 January 2018

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

The spectrum of extrahepatic manifestations in hepatitis C virus infection

21 January 2018

1 reference

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

21 January 2018

1 reference

Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

21 January 2018

1 reference

Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia.

21 January 2018

1 reference

The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection

21 January 2018

1 reference

Neurologic complications associated with hepatitis C virus infection

21 January 2018

1 reference

Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?

21 January 2018

1 reference

Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis

21 January 2018

1 reference

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

21 January 2018

1 reference

Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

21 January 2018

1 reference

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia

21 January 2018

1 reference

Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

21 January 2018

1 reference

Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia

21 January 2018

1 reference

Mixed cryoglobulinaemia associated with hepatitis C virus infection: a predictor factor for treatment with interferon?

21 January 2018

1 reference

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

21 January 2018

1 reference

Selected drug complications and treatment conflicts in the presence of coexistent diseases

21 January 2018

1 reference

Impact of hepatitis B and C virus on kidney transplantation outcome

21 January 2018

1 reference

Hepatitis C viral infection in the immunosuppressed patient

21 January 2018

1 reference

Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis

21 January 2018

1 reference

Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange.

21 January 2018

1 reference

Ribavirin therapy for cryoglobulinemia and thrombocytopenia associated with hepatitis C virus infection.

21 January 2018

1 reference

Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection

21 January 2018

1 reference

Prolonged, complete remission after 2-chlorodeoxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemia

21 January 2018

1 reference

Splenectomy may improve the glomerulopathy of type II mixed cryoglobulinemia

21 January 2018

1 reference

Cryoglobulinemic vasculitis

21 January 2018

1 reference

Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

Dramatic Worsening of Hepatitis C Virus-Related Cryoglobulinemia Subsequent to Treatment With Interferon Alfa

21 January 2018

1 reference

Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy

21 January 2018

1 reference

The effect of combination therapy (steroids, immunosuppressives, and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic, and vascular involvement

21 January 2018

1 reference

Secondary and Essential Cryoglobulinemias

21 January 2018

1 reference

Detection of occult low-grade B-cell non-hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia

21 January 2018

1 reference

Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

21 January 2018

1 reference

Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C

21 January 2018

1 reference

Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C

21 January 2018

1 reference

Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis

21 January 2018

1 reference

Complex management issues: management of HCV in the atypical patient

21 January 2018

1 reference

Treatment of idiopathic mixed cryoglobulinemia with alpha interferon

21 January 2018

1 reference

Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia

21 January 2018

1 reference

Clinical outcome of HCV infection after renal transplantation

21 January 2018

1 reference

Increased susceptibility for CsA-induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis C

21 January 2018

1 reference

Glomerulonephritis in mixed cryoglobulinaemia: what treatment?

21 January 2018

1 reference

Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia

21 January 2018

1 reference

Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection

21 January 2018

1 reference

Etanercept and hepatitis C

21 January 2018

1 reference

Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis

21 January 2018

1 reference

Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity

21 January 2018

1 reference

Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.10107

1 reference

3 August 2017

1 reference